BAD Gene <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">BAD Gene - BCL2-Associated Agonist of Cell Death</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>BAD</td> </tr> <tr> <td class="label">Protein </td> <td>[BAD protein](/proteins/bad-protein)</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>11q13.1</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>573</td> </tr> <tr> <td class="label">UniProt ID </td> <td>Q92934</td> </tr> <tr> <td class="label">Aliases </td> <td>BCL2L8, BBC2</td> </tr> <tr> <td class="label">Regulator</td> <td>Interaction</td> </tr> <tr> <td class="label">[BCL2](/genes/bcl2)</td> <td>Sequestration</td> </tr> <tr> <td class="label">[BCL2L1](/genes/bcl2l1) (BCL-XL)</td> <td>Sequestration</td> </tr> <tr> <td class="label">AKT/PKB</td> <td>Serine phosphorylation</td> </tr> <tr> <td class="label">MAPK</td> <td>Serine phosphorylation</td> </tr> <tr> <td class="label">Interactor</td> <td>Interaction Type</td> </tr> <tr> <td class="label">[BCL2](/genes/bcl2)</td> <td>BH3 binding</td> </tr> <tr> <td class="label">[BCL2L1](/genes/bcl2l1)</td> <td>BH3 binding</td> </tr> <tr> <td class="label">[BAX](/genes/bax)</td> <td>Direct activation</td> </tr> <tr> <td class="label">[BAK1](/genes/bak1)</td> <td>Direct activation</td> </tr> <tr> <td class="label">[MCL1](/genes/mcl1)</td>
...
BAD Gene <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">BAD Gene - BCL2-Associated Agonist of Cell Death</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>BAD</td> </tr> <tr> <td class="label">Protein </td> <td>[BAD protein](/proteins/bad-protein)</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>11q13.1</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>573</td> </tr> <tr> <td class="label">UniProt ID </td> <td>Q92934</td> </tr> <tr> <td class="label">Aliases </td> <td>BCL2L8, BBC2</td> </tr> <tr> <td class="label">Regulator</td> <td>Interaction</td> </tr> <tr> <td class="label">[BCL2](/genes/bcl2)</td> <td>Sequestration</td> </tr> <tr> <td class="label">[BCL2L1](/genes/bcl2l1) (BCL-XL)</td> <td>Sequestration</td> </tr> <tr> <td class="label">AKT/PKB</td> <td>Serine phosphorylation</td> </tr> <tr> <td class="label">MAPK</td> <td>Serine phosphorylation</td> </tr> <tr> <td class="label">Interactor</td> <td>Interaction Type</td> </tr> <tr> <td class="label">[BCL2](/genes/bcl2)</td> <td>BH3 binding</td> </tr> <tr> <td class="label">[BCL2L1](/genes/bcl2l1)</td> <td>BH3 binding</td> </tr> <tr> <td class="label">[BAX](/genes/bax)</td> <td>Direct activation</td> </tr> <tr> <td class="label">[BAK1](/genes/bak1)</td> <td>Direct activation</td> </tr> <tr> <td class="label">[MCL1](/genes/mcl1)</td> <td>BH3 binding</td> </tr> <tr> <td class="label">AKT1</td> <td>Phosphorylation</td> </tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">349 edges</a></td> </tr> </table>
Pathway Diagram
Mermaid diagram (expand to render)
Overview BAD (BCL2-associated agonist of cell death) is a pro-apoptotic member of the BCL-2 family that plays a critical role in regulating mitochondrial-dependent [apoptosis](/entities/apoptosis). It functions as a key initiator of programmed cell death and is implicated in various neurodegenerative diseases where excessive neuronal apoptosis occurs.
Normal Function BAD is a BH3-only pro-apoptotic BCL-2 family member:
Apoptosis initiation : Directly activates BAX/BAK or inhibits anti-apoptotic BCL-2 proteins
Mitochondrial regulation : Controls mitochondrial outer membrane permeabilization (MOMP)
Growth factor signaling : Integrates survival signals from cytokines, growth factors
Phosphorylation : Serine phosphorylation regulates its pro- vs anti-apoptotic activity
Tissue expression : Broad expression, high in lymphoid tissues
Role in Neurodegeneration
Alzheimer's Disease
Neuronal apoptosis : BAD mediates [amyloid-beta](/proteins/amyloid-beta) induced neuronal death
[Tau](/proteins/tau) pathology : BAD activation linked to tau-induced synaptic loss
Synaptic failure : Contributes to synapse elimination in AD
Therapeutic target : BAD inhibitors may protect [neurons](/entities/neurons)
Parkinson's Disease
Dopaminergic neuron death : BAD mediates apoptosis in substantia nigra neurons
[α-synuclein](/proteins/alpha-synuclein) toxicity : BAD activation in response to α-synuclein aggregation
Mitochondrial dysfunction : Interacts with PINK1/Parkin pathway
Neuroprotection : BAD knockout mice show reduced dopaminergic loss
Huntington's Disease
Excitotoxic apoptosis : BAD involved in glutamate-induced neuronal death
Mutant [huntingtin](/proteins/huntingtin) : Increases BAD pro-apoptotic activity
Therapeutic potential : BAD inhibitors show promise in HD models
Amyotrophic Lateral Sclerosis (ALS)
Motor neuron apoptosis : BAD contributes to motor neuron death
Glutamate excitotoxicity : Links excitotoxic signals to mitochondrial apoptosis
Stroke/Ischemia
Ischemic neuronal death : BAD activation in cerebral ischemia
Therapeutic neuroprotection : BAD inhibition reduces infarct size in models
Molecular Mechanisms
Apoptosis Pathway Stress signals → BAD dephosphorylation → Mitochondrial translocation ↓ BAX/BAK activation → MOMP → Cytochrome c release ↓ Apoptosome formation → Caspase-9 activation ↓ Caspase cascade → Cell death
Anti-apoptotic Regulation
Key Interactions
Therapeutic Implications
Inhibitors
BAD mimetics : BH3 mimetics that block BAD's pro-apoptotic function
Indirect inhibitors : BCL-2/BCL-XL inhibitors (navitoclax, venetoclax) indirectly inhibit BAD
Kinase inhibitors : AKT activators could indirectly inhibit BAD
Clinical Status
Direct BAD inhibitors not in clinical trials for neurodegeneration
BCL-2 family inhibitors approved for cancer, being explored for neuroprotection
Gene therapy approaches to reduce BAD expression in development
See Also
[BAD Protein](/proteins/bad-protein)
External Links
[NCBI Gene: BAD](https://www.ncbi.nlm.nih.gov/gene/?term=BAD)
[GeneCards: BAD](https://www.genecards.org/cgi-bin/carddisp.pl?gene=BAD)
[OMIM: BAD](https://omim.org/search?search=BAD)
[Ensembl: BAD](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=BAD)
[Allen Brain Atlas: BAD](https://human.brain-map.org/microarray/search/show?search_term=BAD)
References
[Zheng et al., BAD in neurodegeneration (2023) (2023)](https://doi.org/10.1016/j.tins.2023.05.008)
[Cory et al., BCL-2 family in disease (2022) (2022)](https://doi.org/10.1038/s41573-022-00539-9)
[Unknown, Wang & Youle, BCL-2 proteins in PD (2021) (2021)](https://doi.org/10.1016/j.neuron.2021.08.021)
[O'Neill et al., BAD in stroke (2020) (2020)](https://doi.org/10.1161/STROKEAHA.120.030032)
[Liu et al., BAD in Alzheimer's disease (2019) (2019)](https://doi.org/10.1007/s12017-019-08542-w)
Pathway Diagram The following diagram shows the key molecular relationships involving BAD Gene - BCL2-Associated Agonist of Cell Death discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description